DK0981549T4 - Anvendelse af et inhiberende stof til forbedring af regenereringen af neutroner - Google Patents
Anvendelse af et inhiberende stof til forbedring af regenereringen af neutronerInfo
- Publication number
- DK0981549T4 DK0981549T4 DK98924307T DK98924307T DK0981549T4 DK 0981549 T4 DK0981549 T4 DK 0981549T4 DK 98924307 T DK98924307 T DK 98924307T DK 98924307 T DK98924307 T DK 98924307T DK 0981549 T4 DK0981549 T4 DK 0981549T4
- Authority
- DK
- Denmark
- Prior art keywords
- regeneration
- neutrons
- improve
- inhibitory agent
- neuronal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97107846A EP0878480A1 (en) | 1997-05-14 | 1997-05-14 | A method for the improvement of neuronal regeneration |
| PCT/EP1998/002808 WO1998051708A1 (en) | 1997-05-14 | 1998-05-13 | A method for the improvement of neuronal regeneration |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK0981549T3 DK0981549T3 (da) | 2003-02-10 |
| DK0981549T4 true DK0981549T4 (da) | 2007-10-29 |
Family
ID=8226794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98924307T DK0981549T4 (da) | 1997-05-14 | 1998-05-13 | Anvendelse af et inhiberende stof til forbedring af regenereringen af neutroner |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20020115598A1 (da) |
| EP (2) | EP0878480A1 (da) |
| AT (1) | ATE224915T1 (da) |
| AU (1) | AU7654298A (da) |
| DE (1) | DE69808281T3 (da) |
| DK (1) | DK0981549T4 (da) |
| ES (1) | ES2180175T5 (da) |
| WO (1) | WO1998051708A1 (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0878480A1 (en) * | 1997-05-14 | 1998-11-18 | H.W. Prof. Dr. Müller | A method for the improvement of neuronal regeneration |
| US6200974B1 (en) | 1997-10-24 | 2001-03-13 | Zeneca Limited | Phenanthroline derivatives |
| CN101664553B (zh) * | 2001-12-06 | 2013-08-21 | 法布罗根股份有限公司 | 低氧诱导因子(HIF)α的稳定化 |
| CN102526045A (zh) * | 2001-12-06 | 2012-07-04 | 法布罗根股份有限公司 | 提高内源性红细胞生成素(epo)的方法 |
| US8124582B2 (en) * | 2002-12-06 | 2012-02-28 | Fibrogen, Inc. | Treatment of diabetes |
| US7618940B2 (en) * | 2002-12-06 | 2009-11-17 | Fibrogen, Inc. | Fat regulation |
| DE10314082A1 (de) * | 2003-03-28 | 2004-10-21 | Mcs Micro Carrier Systems Gmbh | Biodegradierbares injizierbares Implantat |
| KR20080044845A (ko) * | 2005-09-02 | 2008-05-21 | 노이락소 바이오파르마슈티컬즈 게엠베하 | 철 킬레이트제를 포함하는 약학적 조성물 |
| WO2007048846A1 (de) * | 2005-10-27 | 2007-05-03 | Neuraxo Biopharmaceuticals Gmbh | Verwendung von eisen chelatisierenden verbindungen, zyklisches adenosinmonophosphat erhöhende verbindungen oder kombinationen davon zur behandlung von axonalen läsionen im zns |
| EP2000134A1 (en) * | 2007-06-06 | 2008-12-10 | Neuraxo Biopharmaceuticals GmbH | Use of a substance for the improvement of pns lesions |
| US9649381B2 (en) | 2013-11-06 | 2017-05-16 | Wayne State University | Transporter protein-coupled nanodevices for targeted drug delivery |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4214000A (en) † | 1978-10-30 | 1980-07-22 | Johnson & Johnson | Zinc salt of all-trans-retinoic acid for the treatment of acne |
| DE3002989A1 (de) * | 1980-01-29 | 1981-07-30 | Hoechst Ag, 6000 Frankfurt | Hydroxyphenyl-thiazol, -thiazolin und -thiazolidin-carbonsaeuren, verfahren zu ihrer herstellung und ihre verwendung zur beeinflussung des kollagenstoffwechsels |
| CA1251729A (en) * | 1982-05-19 | 1989-03-28 | Steffen Gay | In vitro diagnostic methods using monoclonal antibodies against connective tissue proteins |
| DE3432094A1 (de) * | 1984-08-31 | 1986-03-06 | Hoechst Ag, 6230 Frankfurt | Ester der pyridin-2,4- und -2,5- dicarbonsaeure als arzneimittel zur inhibierung der prolin- und lysinhydroxylase |
| US5021404A (en) † | 1988-04-20 | 1991-06-04 | The Children's Medical Center Corporation | Angiostatic collagen modulators |
| WO1993019783A1 (en) * | 1992-04-01 | 1993-10-14 | The Whittier Institute For Diabetes And Endocrinology | Methods of inhibiting or enhancing scar formation in the cns |
| JPH06103773A (ja) † | 1992-09-16 | 1994-04-15 | Hitachi Ltd | 半導体記憶装置 |
| CA2117889A1 (en) * | 1993-02-11 | 1994-08-18 | Martin E. Schwab | A combination of neurotrophin and antibody directed toward myelin-associated neurite growth inhibitory protein promotes central nervous system regeneration |
| EP0732940B1 (en) * | 1993-10-15 | 2001-12-19 | Thomas Jefferson University | Inhibition of extracellular matrix synthesis by antisense compounds directed to c-myc |
| JPH09511219A (ja) * | 1993-11-08 | 1997-11-11 | ニュー ヨーク ユニバーシティ | 神経損傷の治療における神経細胞−グリア細胞間接着分子Ng−CAM |
| US5567609A (en) * | 1994-06-30 | 1996-10-22 | University Of Kansas Medical Center | Use of isolated domains of type IV collagen to modify cell and tissue interactions |
| EP0878480A1 (en) * | 1997-05-14 | 1998-11-18 | H.W. Prof. Dr. Müller | A method for the improvement of neuronal regeneration |
-
1997
- 1997-05-14 EP EP97107846A patent/EP0878480A1/en not_active Withdrawn
-
1998
- 1998-03-13 US US09/423,622 patent/US20020115598A1/en not_active Abandoned
- 1998-05-13 AU AU76542/98A patent/AU7654298A/en not_active Abandoned
- 1998-05-13 DK DK98924307T patent/DK0981549T4/da active
- 1998-05-13 AT AT98924307T patent/ATE224915T1/de not_active IP Right Cessation
- 1998-05-13 EP EP98924307A patent/EP0981549B9/en not_active Expired - Lifetime
- 1998-05-13 WO PCT/EP1998/002808 patent/WO1998051708A1/en not_active Ceased
- 1998-05-13 DE DE69808281T patent/DE69808281T3/de not_active Expired - Lifetime
- 1998-05-13 ES ES98924307T patent/ES2180175T5/es not_active Expired - Lifetime
-
2004
- 2004-05-04 US US10/837,762 patent/US7208153B2/en not_active Expired - Fee Related
-
2007
- 2007-03-16 US US11/723,191 patent/US20070231330A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU7654298A (en) | 1998-12-08 |
| EP0981549A1 (en) | 2000-03-01 |
| DK0981549T3 (da) | 2003-02-10 |
| US7208153B2 (en) | 2007-04-24 |
| DE69808281T2 (de) | 2003-01-16 |
| ATE224915T1 (de) | 2002-10-15 |
| EP0981549B1 (en) | 2002-09-25 |
| EP0981549B2 (en) | 2007-06-27 |
| EP0981549B9 (en) | 2008-02-27 |
| DE69808281D1 (de) | 2002-10-31 |
| ES2180175T3 (es) | 2003-02-01 |
| DE69808281T3 (de) | 2008-01-24 |
| ES2180175T5 (es) | 2008-02-01 |
| US20050118177A1 (en) | 2005-06-02 |
| US20020115598A1 (en) | 2002-08-22 |
| WO1998051708A1 (en) | 1998-11-19 |
| EP0878480A1 (en) | 1998-11-18 |
| US20070231330A1 (en) | 2007-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69201400D1 (de) | Vorrichtung zum Wiederherstellen von gerissenem Gewebe. | |
| DE69531623D1 (de) | Neue benzoxazole | |
| DK0971713T3 (da) | Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser | |
| ES2145915T3 (es) | Derivados estereoquimicos de la wortmannina. | |
| UA27911C2 (uk) | Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну | |
| NO20002172L (no) | FremgangsmÕte for behandling av hyperkolesterolemi med usubstituert polydiallylamin | |
| NO931947D0 (no) | Fremgangsmaate for korrosjonshemming | |
| DE69612003D1 (de) | Substituierte benzolaktamverbindungen als substanz-p-antagonisten | |
| IL122782A0 (en) | Pharmaceutical compositions for treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles | |
| FI944523A7 (fi) | Papilloomaviruksen inhibitio vastinjuosteoligonukleotidilla | |
| NO880772L (no) | Fremgangsmaate til behandling av slam fra avloepsvann. | |
| DK0938326T3 (da) | Syntetiske phosphopeptider til behandling af knoglesygdomme | |
| DK0981549T3 (da) | Anvendelse af inhiberende stof til forbedring af regenereringen af neutroner | |
| DK0687176T3 (da) | Anvendelse af riluzol til behandling af AIDS-relaterede nervesygdomme | |
| ATE425139T1 (de) | Benzamidinderivate | |
| FI933902A7 (fi) | Substituoidut sykloheksaanijohdannaiset sairauksien hoitamiseksi | |
| ID21534A (id) | Konstruksi asam nukleat untuk terapi gen dimana aktifitasnya dipengaruhi oleh inhibitor kinase yang tergantung pada siklin | |
| FI922593L (fi) | Inhibition av papillomavirus med çantisenseç-oligonukleotider. | |
| BR9506552A (pt) | Método de inibição de integrase retroviral | |
| ID17291A (id) | Penghambat matriks metalloprotease oleh asam biaril oksobutirat tersubstitusi | |
| ATE419346T1 (de) | Hemmung der bildung von atherosklerotischen wunden mittels afabp antisens nukleinsäuren | |
| DE69719989D1 (de) | Entfernen von schlamm oder mörtel mittels laser | |
| DE69414891D1 (de) | System zum Erfassen der Rotorbewegung | |
| ES8707495A1 (es) | Un procedimiento para preparar derivados de azetidinona | |
| DK0869785T3 (da) | 4-Hydroxycoumarin-3-carboxyamider til behandling af ikke-insulinafhængig diabetes mellitus |